Accordingly, CAT and other antioxidant enzymes were markedly upregulated in the active demyelinating lesions from patients with progressive MS, in comparison to normal-appearing white matter and white matter tissue from control brains [37]. The gene discussed is CAT; the disease is myeloid sarcoma.